Literature DB >> 26834959

Predicting risk of adverse drug reactions in older adults.

Amanda Hanora Lavan1, Paul Gallagher1.   

Abstract

Adverse drug reactions (ADRs) are common in older adults, with falls, orthostatic hypotension, delirium, renal failure, gastrointestinal and intracranial bleeding being amongst the most common clinical manifestations. ADR risk increases with age-related changes in pharmacokinetics and pharmacodynamics, increasing burden of comorbidity, polypharmacy, inappropriate prescribing and suboptimal monitoring of drugs. ADRs are a preventable cause of harm to patients and an unnecessary waste of healthcare resources. Several ADR risk tools exist but none has sufficient predictive value for clinical practice. Good clinical practice for detecting and predicting ADRs in vulnerable patients includes detailed documentation and regular review of prescribed and over-the-counter medications through standardized medication reconciliation. New medications should be prescribed cautiously with clear therapeutic goals and recognition of the impact a drug can have on multiple organ systems. Prescribers should regularly review medication efficacy and be vigilant for ADRs and their contributory risk factors. Deprescribing should occur at an individual level when drugs are no longer efficacious or beneficial or when safer alternatives exist. Inappropriate prescribing and unnecessary polypharmacy should be minimized. Comprehensive geriatric assessment and the use of explicit prescribing criteria can be useful in this regard.

Entities:  

Keywords:  adverse drug reaction; inappropriate prescribing; polypharmacy; predictive value; risk assessment

Year:  2016        PMID: 26834959      PMCID: PMC4716390          DOI: 10.1177/2042098615615472

Source DB:  PubMed          Journal:  Ther Adv Drug Saf        ISSN: 2042-0986


  74 in total

Review 1.  Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Authors:  A A Mangoni; S H D Jackson
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

2.  Patterns of drug prescription in a geriatric evaluation and management unit as compared with the general medical wards: a randomised study.

Authors:  Ingvild Saltvedt; Olav Spigset; Sabine Ruths; Peter Fayers; Stein Kaasa; Olav Sletvold
Journal:  Eur J Clin Pharmacol       Date:  2005-11-24       Impact factor: 2.953

3.  Standardized assessment of drug-adverse reaction associations--rationale and experience.

Authors:  J Venulet; A Ciucci; G C Berneker
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980-09

Review 4.  Optimising drug treatment for elderly people: the prescribing cascade.

Authors:  P A Rochon; J H Gurwitz
Journal:  BMJ       Date:  1997-10-25

5.  The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old.

Authors:  Inga Klarin; Anders Wimo; Johan Fastbom
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  Pharmacological and clinical profile of newer antidepressants: implications for the treatment of elderly patients.

Authors:  Christian Dolder; Michael Nelson; Andrea Stump
Journal:  Drugs Aging       Date:  2010-08-01       Impact factor: 3.923

7.  Adverse drug reaction risk factors in older outpatients.

Authors:  Emily R Hajjar; Joseph T Hanlon; Margaret B Artz; Catherine I Lindblad; Carl F Pieper; Richard J Sloane; Christine M Ruby; Kenneth E Schmader
Journal:  Am J Geriatr Pharmacother       Date:  2003-12

8.  Clinical pharmacogenetics implementation consortium guidelines for CYP2C9 and HLA-B genotypes and phenytoin dosing.

Authors:  K E Caudle; A E Rettie; M Whirl-Carrillo; L H Smith; S Mintzer; M T M Lee; T E Klein; J T Callaghan
Journal:  Clin Pharmacol Ther       Date:  2014-08-06       Impact factor: 6.875

9.  STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria.

Authors:  Paul Gallagher; Denis O'Mahony
Journal:  Age Ageing       Date:  2008-10-01       Impact factor: 10.668

Review 10.  Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies.

Authors:  Chuenjid Kongkaew; Peter R Noyce; Darren M Ashcroft
Journal:  Ann Pharmacother       Date:  2008-07-01       Impact factor: 3.154

View more
  81 in total

Review 1.  Withdrawal of Antidementia Drugs in Older People: Who, When and How?

Authors:  Carole Parsons
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

2.  Longitudinal Investigation of Older Adults' Ability to Self-Manage Complex Drug Regimens.

Authors:  Stacy Cooper Bailey; Lauren A Opsasnick; Laura M Curtis; Alex D Federman; Julia Y Benavente; Rachel O'Conor; Michael S Wolf
Journal:  J Am Geriatr Soc       Date:  2019-11-25       Impact factor: 5.562

3.  Suspected adverse drug reactions (ADRs) trends in older Italian patients: an analysis from the National Pharmacovigilance Network.

Authors:  Gianluca Sferrazza; Giuseppe Nicotera; Pasquale Pierimarchi
Journal:  Aging Clin Exp Res       Date:  2019-08-19       Impact factor: 3.636

Review 4.  Identification and management of frailty in the primary care setting.

Authors:  Marjan Abbasi; Darryl Rolfson; Amandeep S Khera; Julia Dabravolskaj; Elsa Dent; Linda Xia
Journal:  CMAJ       Date:  2018-09-24       Impact factor: 8.262

5.  Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients.

Authors:  Michelle A Arms; James Fleming; Deep B Sangani; Satish N Nadig; John W McGillicuddy; David J Taber
Journal:  Surgery       Date:  2017-11-22       Impact factor: 3.982

Review 6.  Using Information Technology in the Assessment and Monitoring of Geriatric Oncology Patients.

Authors:  Kah Poh Loh; Colin McHugh; Supriya G Mohile; Karen Mustian; Marie Flannery; Heidi Klepin; Rebecca Schnall; Eva Culakova; Erika Ramsdale
Journal:  Curr Oncol Rep       Date:  2018-03-06       Impact factor: 5.075

7.  Predicting the Risk of Adverse Drug Reactions in Older Inpatients: External Validation of the GerontoNet ADR Risk Score Using the CRIME Cohort.

Authors:  Mirko Petrovic; Balamurugan Tangiisuran; Chakravarthi Rajkumar; Tischa van der Cammen; Graziano Onder
Journal:  Drugs Aging       Date:  2017-02       Impact factor: 3.923

8.  Implementing a screening tool to improve prescribing in hospitalized older patients: a pilot study.

Authors:  Anne-Laure Sennesael; Olivia Dalleur; Séverine Henrard; Charline Artoisenet; Didier Schoevaerdts; Anne Spinewine
Journal:  Int J Clin Pharm       Date:  2017-11-23

Review 9.  High-risk medication in community care: a scoping review.

Authors:  Irina Dumitrescu; Minne Casteels; Kristel De Vliegher; Tinne Dilles
Journal:  Eur J Clin Pharmacol       Date:  2020-02-05       Impact factor: 2.953

10.  An evaluation of a potential calcium channel blocker-lower-extremity edema-loop diuretic prescribing cascade.

Authors:  Scott Martin Vouri; Joseph S van Tuyl; Margaret A Olsen; Hong Xian; Mario Schootman
Journal:  J Am Pharm Assoc (2003)       Date:  2018-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.